Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.
NCT00158704
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
400
Enrollment
INDUSTRY
Sponsor class
Stopped
The study stopped due to marketing approval by the FDA.
Conditions
Hepatitis B
Interventions
DRUG:
Hepsera
Sponsor
Gilead Sciences